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Summary：Malnutrition frequently occurs in end-stage hepatocellular carcinoma patients, and can 
influence survival in the patients.  The objective of the present study was to investigate the relationships 
between clinical and dietary indices in the patients.  The clinical data of 33 patients affected by hepa-        
tocellular carcinoma (stage IV) who had been hospitalized to receive chemotherapy were retrospectively 
analyzed.  A multiple regression analysis was performed based on the blood data (albumin, total bilirubin, 
direct bilirubin, AST, ALT, LDH, ALP, α-fetoprotein, and C-reactive protein) and the mean values of daily 
dietary indices (intake rate, dietary intake, energy intake, NaCl intake, iron intake, zinc intake, and vita-        
min K intake) during hospitalization.  Both the intake rate and the zinc intake were significantly 
correlated with the C-reactive protein and α-fetoprotein levels, while the albumin level was significantly 
correlated with the zinc intake and the ALT level.  These results showed that zinc deficiency is correlated 
with a relatively poor prognosis.  Thus, it is necessary to improve the problem in the affected patients.
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Introduction
　Hepatocellular carcinoma is the third leading cause of 
death from cancer in Japan, and conservative palliative 
care is very important for patients affected by this carci- 
noma1, 2）.  Malnutrition frequently occurs in end-stage 
hepatocellular carcinoma patients, regardless of the 
presence of liver cirrhosis, and may represent a risk 
factor influencing both short-term and long-term survival 
in these patients3-6）.  For example, hypoalbuminemia has 
been often found in patients during the end stages of 
hepatocellular carcinoma.  Consequently, the disorder 
leads to a contraindication for chemotherapy7）.  One of 
the most important causes of nutritional disorders in 
these patients is obviously their low dietary intake, 
which automatically induces an insufficiency of such 
micronutrients as iron (Fe) and zinc (Zn).  Impairments 
in dietary intake may therefore influence the clinical 
condition of hepatocellular carcinoma.  However, the 
relationship between the clinical and dietary indices in 
patients affected by hepatocellular carcinoma has not yet 
been fully analyzed.  The objective of the present study 
was to investigate the relationship between clinical and 
dietary indices in the patients with end-stage hepatocel- 
lular carcinoma using a multiple regression analysis.
Materials and Methods
　1)　Patients
　The clinical data of 33 patients with the carcinoma 
(stage IV) who were hospitalized to receive chemotherapy 
at Kyoundo Hospital were retrospectively analyzed.  The 
patient profiles are shown in Table 1.  All the patients 
had an abnormally high range of α-fetoprotein (AFP), did 
not receive intravenous hyperalimentation, and were 
eventually discharged under their own power.  Blood 
data (serum concentrations of albumin [Alb], total 
bilirubin [T-Bil], direct bilirubin [D-Bil], aspartate amino- 
transferase [AST], alanine aminotransferase [ALT], 
lactate dehydrogenase [LDH], alkaline phosphatase [ALP], 
AFP, and C-reactive protein [CRP]) were used for the 
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analysis.  The mean values for the dietary indices during 
hospitalization were calculated based on the daily dietary 
intakes (g/day), the intake rates (%), and the nutrient 
values for the provided meals (energy, NaCl, Fe, Zn, 
vitamin K).  The dietary intake (g/day) was calculated 
by subtracting the leftover amounts (g/day) from the 
provided meals (g/day).  The intake rate (%) was calcu- 
lated by dividing the dietary intake (g/day) by the pro- 
vided meals (g/day).  The nutrient intake contents were 
calculated by multiplying the intake rate by the nutrient 
values for the provided meals (g/day).
　2)　Statistical analysis
　All the data were presented as the mean values ±SD. 
A simple linear regression analysis was performed to 
evaluate the association between the two variables, and 
a multiple linear regression analysis was also performed 
using SPSS for Windows (Ver. 11.0J, SPSS Japan Inc.).  In 
the case of multicollinearity, some of the variables that 
demonstrated a lower correlation to the dependent 
variables were excluded.  A value of P＜0.05 was con- 
sidered to indicate statistical significance.
Results
　The blood data, the dietary data, and the correlation 
coefficients among variables are shown in Tables 2, 3 and 
4, respectively.  The intake rate was significantly corre- 
lated with age and the CRP, Alb, AFP, D-Bil and T-Bil 
levels in simple regression analyses.  A multiple regres- 
sion analysis for the intake rate and four explanatory 
variables (CRP, Alb, AFP, and D-Bil) revealed significant 
correlations (r＝0.727, P＜0.001) with the CRP (r＝－0.468, 
P＜0.01) and AFP (r＝－0.350, P＜0.05) levels.  Two 
explanatory variables (age and T-Bil) were excluded 
from the multiple regression analysis because of 
multicollinearity with Alb and D-Bil, respectively.
　The CRP level was significantly correlated with the Zn 
intake, the intake rate, and the LDH, Alb, and AST levels 
according to simple regression analyses.  A multiple 
regression analysis for the CRP level that included three 
explanatory variables (Zn, LDH, and Alb) revealed a 
significant correlation (r＝0.643, P＜0.005) with the Zn 
intake (r＝－0.529, P＜0.005) ; one explanatory variable 
(ALT) was excluded from the analysis because of multi- 
collinearity with the LDH level.
　The AFP level was significantly correlated with the 
intake rate, Zn intake, and the T-Bil and D-Bil levels 
according to simple regression analyses.  A multiple 
regression analysis for the AFP level that included three 
explanatory variables (intake rate, T-Bil level, and Zn 
intake) failed to show any significant correlation; one 
explanatory variable (D-Bil) was excluded from the 
analysis because of multicollinearity with the T-Bil level.
　The Zn intake was significantly correlated with age 
and the CRP, Alb, AFP, and D-Bil levels according to 
simple regression analyses.  A multiple regression analysis 
Table 2　Blood data (n＝33)Table 1　Subjects profiles (n＝33)
Table 3　Daily dietary indices (n＝33)
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for the Zn intake that included four explanatory vari- 
ables (CRP, Alb, AFP, and D-Bil) revealed significant 
correlations (r＝0.750, P＜0.001) with the CRP (r＝－0.472, 
P＜0.005) and AFP (r＝－0.324, P＜0.05) levels ; one 
explanatory variable (age) was excluded because of mul- 
ticollinearity with the Alb level.
　The Alb level was significantly correlated with the Zn 
intake, intake rate, age, and the T-Bil, D-Bil, AST, CRP, 
and ALT levels according to simple regression analyses. 
A multiple regression analysis for the Alb level that 
included six explanatory variables (T-Bil, Zn, age, AST, 
CRP, and ALT) failed to reveal any significant corre- 
lations ; two explanatory variables (D-Bil and intake rate) 
were excluded because of multicollinearity with the T-Bil 
level.  Next, a multiple regression analysis for the Alb 
level that included four explanatory variables (T-Bil, Zn, 
age, and ALT) and that had a lower probability (P value) 
was re-performed, resulting in a significant correlation (r
＝0.736, P＜0.001) with the Zn intake (r＝0.319, P＜0.05) 
and the ALT level (r＝－0.299, P＜0.05).
Discussion
　The intake rate is undeniably important for maintaining 
a good nutritional condition in patients in the end-stage 
who are not receiving intravenous hyperalimentation. 
By combining simple and multiple linear regression ana- 
lyses, we revealed that the CRP and AFP levels influence 
the intake rate and that the Zn intake, in turn, influences 
the CRP level.  No factors that influenced the AFP level 
were identified.  We then revealed that the CRP and 
AFP levels influence the Zn intake, while the Zn intake 
influences the Alb level.  The Alb level was also influ- 
enced by the intake rate ; however, the effect of the 
intake rate (r＝0.483) on the Alb level was smaller than 
that of the Zn intake (r＝0.536).  As a result, Zn intake 
was found to be closely related to the CRP, AFP, and 
Alb levels.  The CRP and AFP levels indicate the activ- 
ity of carcinoma, while the Alb level reflects the nutri- 
tional status.  The amount of Zn (6.0±2.0 mg/day) con- 
sumed by the patients investigated herein was below the 
recommended amount (11 mg/day), even though the 
Table 4　Correlation coefficients among variables
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patients’ energy intake (1268±371 kcal/day) was consid- 
ered to be within the satisfactory range.  Therefore, Zn 
deficiency may cause a deterioration in the nutritional 
status and prognosis of patients with hepatocellular 
carcinoma.
　Zn also acts as an antioxidant to protect proteins and 
DNA8-10） and is important for host defense against the 
initiation and progression of cancer11）.  In addition, Zn 
deficiency decreases one’s ability to taste12）.  An impair- 
ment in gustatory acuity may thus influence nutrient 
intake and hence negatively impact the nutritional status, 
such as causing an increase in Na intake resulting in 
edema and ascites.  Zn deprivation also induces deterio- 
rations in both liver cirrhosis and hepatic encephalopathy13）. 
The usefulness of Zn supplement in the treatment of 
liver disease has already been reported14）.  These results 
showed that Zn deficiency is correlated with a relatively 
poor prognosis.  Thus, it is necessary to improve the pro- 
blem in the affected patients.
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化学療法下にある末期肝細胞癌患者の亜鉛欠乏
本間和宏*・和田安代*・榎本真理**・小尾俊太郎***・若菜宣明*・田中越郎*
（平成 25 年 5 月 15 日受付/平成 25 年 9 月 10 日受理）
要約：末期肝細胞癌患者では栄養状態の悪化が多く見られ，これは予後を左右する重要な因子である。化学
療法目的で入院した 33 名の IV 期肝細胞癌患者で，食事摂取状況と臨床検査データとの関連を調べた。血
清中の直接ビリルビン，間接ビリルビン，LDH, AST, ALT, ALP, アルブミン，CRP, AFP さらに入院中
の平均食事摂取率，食事摂取量，摂取エネルギー量，摂取食塩相当量，鉄摂取量，亜鉛摂取量，ビタミン K
摂取量および年齢を変数として重相関分析を行った。食事摂取率に影響を及ぼしているものは CRP と AFP
であり，CRP に影響を及ぼしているものは亜鉛摂取量であった。亜鉛摂取量に影響を及ぼしているものは
CRP と AFP であり，亜鉛摂取量はアルブミンにも影響を及ぼしていた。以上の結果から，亜鉛欠乏は本病
状と深い関係があることを示しており，これらの患者においてこの問題を改善することが必要と考える。
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